Insider · CIK 0001132945

COHEN MARC A

Reports to the SEC for 3 companies · BETHESDA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001132945

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-22	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2022-06-21	KRROKorro Bio, Inc. · Stock OptionA Award	Director	AAward	+14.8K sh	—	—	14,846
2022-01-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+657 sh	$31.58	+$20.7K	1,118
2021-10-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+461 sh	$44.99	+$20.7K	461
2021-07-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+522 sh	$39.72	+$20.7K	6,641
2021-06-17	KRROKorro Bio, Inc. · Stock OptionA Award	Director	AAward	+14.8K sh	—	—	14,846
2021-06-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-06-14	CCCCC4 Therapeutics, Inc.J Other	Director	JOther	+92.8K sh	—	—	98,936
2021-06-14	CCCCC4 Therapeutics, Inc.J Other	Director	JOther	+22.6K sh	—	—	1,874,805
2021-04-05	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+553 sh	$37.51	+$20.7K	6,119
2021-02-18	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+536 sh	$2.11	+$1,130.96	5,566
2021-02-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−536 sh	—	—	3,209
2020-10-06	CCCCC4 Therapeutics, Inc.C Conversion	Director	CConversion	+237K sh	—	—	370,024
2020-10-06	CCCCC4 Therapeutics, Inc.P Purchase	Director	PPurchase	+5,030 sh	$19.00	+$95.6K	5,030
2020-10-06	CCCCC4 Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−21M sh	—	—	0
2020-10-06	CCCCC4 Therapeutics, Inc.C Conversion	Director	CConversion	+2.48M sh	—	—	2,484,425
2020-10-06	CCCCC4 Therapeutics, Inc. · Series Seed Preferred StockC Conversion	Director	CConversion	−2M sh	—	—	0
2020-10-06	CCCCC4 Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−12.5M sh	—	—	0
2020-10-06	CCCCC4 Therapeutics, Inc.C Conversion	Director	CConversion	+1.48M sh	—	—	1,852,207
2020-10-01	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,786
2020-10-01	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+725K sh	—	—	725,002
2020-06-11	KRROKorro Bio, Inc. · Stock OptionA Award	Director	AAward	+14.8K sh	—	—	14,846
2020-01-30	KRROKorro Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+21.8K sh	$3.37	+$73.6K	564,264
2020-01-30	KRROKorro Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,042 sh	$0.61	+$4,905.62	525,746
2020-01-30	KRROKorro Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20.8K sh	$3.37	+$70K	585,042
2020-01-30	KRROKorro Bio, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20.8K sh	—	—	0
2020-01-30	KRROKorro Bio, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−21.8K sh	—	—	32,918
2020-01-30	KRROKorro Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20.8K sh	$3.37	+$70K	605,820
2020-01-30	KRROKorro Bio, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−8,042 sh	—	—	12,063
2020-01-30	KRROKorro Bio, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	—	—	50,072
2020-01-30	KRROKorro Bio, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20.8K sh	—	—	0
2020-01-30	KRROKorro Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$0.61	+$10.2K	542,437
2019-12-03	KRROKorro Bio, Inc. · Stock OptionA Award	Director	AAward	+20.8K sh	—	—	20,778
2019-10-07	KRROKorro Bio, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−543K sh	—	—	0
2019-10-07	KRROKorro Bio, Inc.C Conversion	Director	CConversion	+445K sh	—	—	517,704
2019-10-07	KRROKorro Bio, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−163K sh	—	—	0
2019-10-07	KRROKorro Bio, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−2.29M sh	—	—	0
2019-10-07	KRROKorro Bio, Inc.P Purchase	Director	PPurchase	+17.9K sh	$14.00	+$250K	17,857
2012-12-18	OPNET TECHNOLOGIES INCD Disposition to Issuer	Director, Chairman, CEO, Treas & Secy, 10% Owner	DDisposition to Issuer	−5,290 sh	$41.78	−$221K	0
2012-12-18	OPNET TECHNOLOGIES INCF Tax Payment	Director, Chairman, CEO, Treas & Secy, 10% Owner	FTax Payment	−3,861 sh	$41.72	−$161K	5,290
2012-12-18	OPNET TECHNOLOGIES INCU Disposition from Tender	Director, Chairman, CEO, Treas & Secy, 10% Owner	UDisposition from Tender	−2.78M sh	$41.78	−$116M	9,151
2012-11-14	OPNET TECHNOLOGIES INCM Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	+48K sh	$11.75	+$564K	2,791,899
2012-11-14	OPNET TECHNOLOGIES INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	−48K sh	—	—	0
2012-06-14	OPNET TECHNOLOGIES INCM Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	+38K sh	$5.85	+$222K	2,756,222
2012-06-14	OPNET TECHNOLOGIES INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	−38K sh	—	—	0
2012-06-14	OPNET TECHNOLOGIES INCS Sale	Director, Chairman, CEO, Treas & Secy, 10% Owner	SSale	−12.3K sh	$24.68	−$304K	2,743,899
2012-06-13	OPNET TECHNOLOGIES INCS Sale	Director, Chairman, CEO, Treas & Secy, 10% Owner	SSale	−12K sh	$24.32	−$292K	2,718,222
2012-06-13	OPNET TECHNOLOGIES INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	−12K sh	—	—	38,000
2012-06-13	OPNET TECHNOLOGIES INCM Exercise/Conversion	Director, Chairman, CEO, Treas & Secy, 10% Owner	MExercise/Conversion	+12K sh	$5.85	+$70.2K	2,730,222
2012-02-09	OPNET TECHNOLOGIES INCA Award	Director, Chairman, CEO, Treas & Secy, 10% Owner	AAward	+1,167 sh	—	—	2,718,222

Recent filings

Accepted (ET)
Jun 234
COHEN MARC A0001127602-22-018038
SEC(opens sec.gov)
Jun 234
COHEN MARC A0001209191-22-038863
SEC(opens sec.gov)
Jan 184
COHEN MARC A0001209191-22-003503
SEC(opens sec.gov)
Oct 54
COHEN MARC A0001209191-21-059522
SEC(opens sec.gov)
Jul 74
COHEN MARC A0001209191-21-045807
SEC(opens sec.gov)
Jun 214
COHEN MARC A0001127602-21-020399
SEC(opens sec.gov)
Jun 174
COHEN MARC A0001209191-21-041423
SEC(opens sec.gov)
Jun 144
COHEN MARC A0001209191-21-040278
SEC(opens sec.gov)
Apr 64
COHEN MARC A0001209191-21-025661
SEC(opens sec.gov)
Feb 194
COHEN MARC A0001209191-21-012339
SEC(opens sec.gov)
Oct 64
COHEN MARC A0000899243-20-027697
SEC(opens sec.gov)
Oct 54
COHEN MARC A0000899243-20-027447
SEC(opens sec.gov)

Companies

Address

7255 WOODMONT AVE

BETHESDA, MD, 20814